Personalized Medicine in Oncology™ the official publication of the Global Biomarkers™

Member Type: Strategic Partners

The goal of Personalized Medicine in Oncology™ is to sensitize practitioners to the performance realities of new diagnostic and treatment discoveries and clarify molecular profiling technology as it relates to diagnostic, prognostic, and predictive medicine. The Global Biomarkers Consortium™ (GBC) is a community of world-renowned healthcare professionals that will convene in multiple educational forums in order to better understand the clinical application of predictive molecular biomarkers and advanced personalized care for patients.

Join Today

Contact Mary Bordoni, Director, Membership & Development, for information about joining the Coalition.

Download a Member List